HCA医疗 2026年季度报告

Form 10-Q (Mark One) HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Indicate by check mark whether the registrant (1) has filed all reports required to be filed bySection 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or forsuch shorter period that the registrant was required to file such reports), and (2) has been subject tosuch filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every InteractiveData File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of thischapter) during the preceding 12 months (or for such shorter period that the registrant was requiredto submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,a non-accelerated filer, smaller reporting company or an emerging growth company. See thedefinitionsof“large accelerated filer,”“accelerated filer,”“smaller reporting company”and“emerging growth company” in Rule 12b-2 of the Exchange Act. HCA HEALTHCARE, INC.Form 10-QJune 30, 2026 Part I.Financial Information Item 1.Financial Statements (Unaudited):Condensed Consolidated Income Statements — for the quarters and six monthsended June 30, 2026 and 20253Condensed Consolidated Comprehensive Income Statements — for the quartersand six months ended June 30, 2026 and 20254Condensed Consolidated Balance Sheets — June 30, 2026 and December 31,20255Condensed Consolidated Statements of Stockholders’ Equity (Deficit) — forthe quarters and six months ended June 30, 2026 and 20256Condensed Consolidated Statements of Cash Flows — for the six months endedJune 30, 2026 and 20257Notes to Condensed Consolidated Financial Statements8Item 2.Management’s Discussion and Analysis of Financial Condition and Results ofOperations17Item 3.Quantitative and Qualitative Disclosures About Market Risk31Item 4.Controls and Procedures31Part II.Other InformationItem 1.Legal Proceedings31Item 1A.Risk Factors31Item 2.Unregistered Sales of Equity Securities and Use of Proceeds31Item 5.Other Information32Item 6.Exhibits32Signatures33 HCA HEALTHCARE, INC.CONDENSED CONSOLIDATED INCOME STATEMENTSFOR THE QUARTERS AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025Unaudited(Dollars in millions, except per share amounts) HCA HEALTHCARE, INC.CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTSFOR THE QUARTERS AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025Unaudited(Dollars in millions) HCA HEALTHCARE, INC.CONDENSED CONSOLIDATED BALANCE SHEETSUnaudited(Dollars in millions) HCA HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’EQUITY (DEFICIT)FOR THE QUARTERS AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025Unaudited(Dollars in millions) HCA HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSFOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025Unaudited(Dollars in millions) NOTE 1 — BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTINGPOLICIES Reporting Entity HCA Healthcare, Inc. is a holding company whose affiliates own and operatehospitals and related health care entities. The term “affiliates” includes direct andindirect subsidiaries of HCA Healthcare, Inc. and partnerships and joint ventures inwhich such subsidiaries are partners. At June 30, 2026, these affiliates owned andoperated 190 hospitals, 118 freestanding surgery centers and 30 freestanding endoscopycenters and provided extensive outpatient and ancillary services. HCA Healthcare,Inc.’s facilities are located in 19 states and England. The terms “Company,” “HCA,”“we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context,refer to HCA Healthcare, Inc. and its affiliates. The terms “facilities” or “hospitals”refer to entities owned and operated by affiliates of HCA and the term “employees”refers to employees of affiliates of HCA. Basis of Presentation The accompanying unaudited condensed consolidated financial statements havebeen prepared in accordance with generally accepted accounting principles for interimfinancial information and with the instructions to Form 10-Q and Article 10 ofRegulation S-X. Accordingly, they do not include all the information and footnotesrequiredby generally accepted accounting principles for complete consolidatedfinancialstatements.In the opinion of management,all adjustments considerednecessary for a fair presentation have been included and are of a normal and recurringnature. The majority of our expenses are “costs of revenues” items. Costs that could beclassified as general and administrative would include our corporate office costs, whichwere $148 million and $130 million for the quarters ended June 30, 2026 and 2025,respectively, and $281 million and $256 million for the six months ended June 30, 2026and 2025, respectively. Operating results for the quarter and six months ended June 30,2026 are not necessarily indicative of the results that may be expected for the yearending